window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Digital Health

  • Clinical Development,Clinical studies,Digital Health,FDA,Medical devices,Technology and platforms

    Viz.ai, Johnson & Johnson strike US chronic subdural hematoma AI deal

    Viz.ai has entered a collaboration with Johnson & Johnson to [...]

    April 22, 2026
  • Clinical Development,Clinical Trials,Digital Health,Funding,Mental health,Neurosciences,Pharmaceuticals and therapeutics

    Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy

    Click Therapeutics has secured a $50M Series D investment from [...]

    April 10, 2026
  • Artificial Intelligence,Diagnostics,Digital Health,Medical devices,Women's Health

    Diagnoly launches Fetoly on iOS for real-time fetal ultrasound AI

    Diagnoly has launched its fetal ultrasound AI tool Fetoly on [...]

    April 7, 2026
  • Artificial Intelligence,Digital Health,Mental health,Neurosciences,Research & Development

    Bullfrog AI signs commercial agreement with top 5 global pharma company to identify novel target in major depressive disorder

    BullFrog AI Holdings has entered a commercial agreement with a [...]

    March 30, 2026
  • Biotech,Digital Health,Research & Development

    Ribbon CEO calls for faster adoption of AI and DNA synthesis to accelerate drug development

    The chief executive of Ribbon Biolabs has called for faster [...]

    March 27, 2026
  • Clinical studies,Digital Health,Global health,Mental health,Neurosciences

    Young adults in US, UK and Australia hit hardest by global mental health decline

    Young adults in wealthy countries are four times more likely [...]

    February 25, 2026
  • Clinical studies,Digital Health,Drug Delivery & Formulation,Neurosciences

    Study confirms Nerivio REN wearable safe with continuous glucose monitoring devices

    A new study confirms that Theranica’s Nerivio REN wearable for [...]

    February 25, 2026
  • Artificial Intelligence,Digital Health,Funding,Healthcare leadership,Pharmaceuticals and therapeutics

    Brainomix extends Series C to $25.4M to support US expansion

    Brainomix has extended its Series C financing by $6.5M (£4.8M), [...]

    February 24, 2026
  • Artificial Intelligence,Clinical Development,Digital Health,Drug Development,Technology and platforms

    Evinova secures collaborations with Astellas, AstraZeneca and Bristol Myers Squibb to share clinical trial data for AI benchmarking

    Evinova has announced collaborations with Astellas Pharma, AstraZeneca and Bristol [...]

    February 19, 2026
  • Artificial Intelligence,Data Management,Digital Health,Pharmaceuticals and therapeutics,Technology and platforms

    Within3 launches Dataverse to integrate real-world data into pharma launch intelligence platform

    Within3 has launched Dataverse, a partner ecosystem designed to extend [...]

    February 18, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top